UNSW researchers target invisible heart disease in women
UNSW Sydney researchers are launching the RESTORE trial to address coronary microvascular dysfunction (CMD), a form of 'invisible heart disease' that disproportionately affects women. The study aims to develop female-specific treatments for the condition.
Why it matters
It addresses a significant gender gap in cardiovascular medicine, where diagnostic and treatment protocols have historically been based on male biology.
UNSW researchers have secured support through Wellcome Leap’s VISIBLE program, a global research initiative in women’s cardiovascular health.
The article reports on medical research and health equity without bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in